<DOC>
	<DOCNO>NCT01328366</DOCNO>
	<brief_summary>The impact psoriasis individual 's emotional social well-being go beyond skin symptom disease . Data suggest patient severe psoriasis experience great prevalence depressive symptom , mood disturbance , anxiety even suicidal ideation . Given nature disease treatment failure require patient commences biologic therapy adalimumab , patient 's mental health initiation biologics important consideration clinician . This study seek explore adalimumab treatment psoriasis lead positive impact psychosocial factor disease-related quality life .</brief_summary>
	<brief_title>Quality Life Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab</brief_title>
	<detailed_description>This multi-center , prospective , post-marketing observational study participant severe chronic plaque psoriasis begin adalimumab therapy United Kingdom . Although 153 participant enrol study , data analyze 143 individual intervention change participant management study . Prior initiate adalimumab therapy ( baseline ) , Dermatology Life Quality Index ( DLQI ) , Self-Administered Psoriasis Area Severity Index ( SAPASI ) , Hospital Anxiety Depression Scale ( HADS ) , Cutaneous Body Image ( CBI ) scale , Short Form 12 ( SF-12 ) Health Survey , Female Sexual Function Index ( FSFI ) ( female participant ) International Index Erectile Function ( IIEF ) ( male participant ) questionnaire complete participant 4 week , 16 week 6 month follow initiation .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Participants eligible adalimumab determine National Institute Health Clinical Excellence ( NICE ) criteria Participants severe psoriasis define Psoriasis Area Severity Index ( PASI ) 10 Dermatology Life Quality Index ( DLQI ) 10 Participant 's psoriasis respond standard systemic therapy , include : ciclosporin , methotrexate , psoralen longwave ultraviolet radiation ; participant intolerant contraindication treatment Participants previously treat another biologic therapy Participants unable unwilling complete study questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Quality Life</keyword>
	<keyword>Psychosocial factor</keyword>
</DOC>